日本調剤(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証PRM | 小売業 | 3341/E05422 | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2015/02/27 | 日証協 | 118,164株 | -0.41% | 40,889株 | +5741.29% | 118,166株 | -0.15% | 15,907株 | +1120.8% |
| 2015/02/20 | 日証協 | 118,654株 | +2.77% | 700株 | -86.49% | 118,347株 | -1.14% | 1,303株 | -69.43% |
| 2015/02/13 | 日証協 | 115,454株 | +1.39% | 5,180株 | -74.41% | 119,707株 | +0.64% | 4,263株 | +21.8% |
| 2015/02/06 | 日証協 | 113,874株 | -2.92% | 20,243株 | +820.14% | 118,944株 | -4.67% | 3,500株 | +1421.74% |
| 2015/01/30 | 日証協 | 117,294株 | -1.98% | 2,200株 | -87.94% | 124,774株 | -3.56% | 230株 | -42.5% |
| 2015/01/23 | 日証協 | 119,664株 | 0% | 18,243株 | +3615.48% | 129,374株 | -0.85% | 400株 | -60% |
| 2015/01/16 | 日証協 | 119,664株 | +0.16% | 491株 | -95.83% | 130,486株 | -0.45% | 1,000株 | -91.36% |
| 2015/01/09 | 日証協 | 119,473株 | +7.63% | 11,770株 | +5531.58% | 131,082株 | +6.15% | 11,574株 | +4474.7% |
| 2014/12/30 | 日証協 | 111,003株 | -0.54% | 209株 | -98.81% | 123,482株 | +0.4% | 253株 | -87.41% |
| 2014/12/26 | 日証協 | 111,603株 | +0.85% | 17,512株 | -41.36% | 122,991株 | +9.13% | 2,010株 | -91.1% |
| 2014/12/19 | 日証協 | 110,663株 | +10.79% | 29,862株 | +1144.25% | 112,704株 | +17.81% | 22,595株 | +153.82% |
| 2014/12/12 | 日証協 | 99,883株 | +0.27% | 2,400株 | -91.55% | 95,668株 | +0.77% | 8,902株 | -1.2% |
| 2014/12/05 | 日証協 | 99,613株 | +9.62% | 28,402株 | +105.07% | 94,941株 | +7.07% | 9,010株 | +276.51% |
| 2014/11/28 | 日証協 | 90,873株 | -0.76% | 13,850株 | -22.94% | 88,671株 | -2.87% | 2,393株 | -40.17% |
| 2014/11/21 | 日証協 | 91,573株 | -0.13% | 17,974株 | +3494.8% | 91,288株 | -0.81% | 4,000株 | +67.64% |
| 2014/11/14 | 日証協 | 91,693株 | -8.63% | 500株 | +66.67% | 92,038株 | -5.96% | 2,386株 | -88.39% |
| 2014/11/07 | 日証協 | 100,350株 | -0.69% | 300株 | -96.05% | 97,869株 | -1.41% | 20,556株 | +1839.25% |
| 2014/10/31 | 日証協 | 101,050株 | -5.77% | 7,589株 | +110.81% | 99,273株 | -10.55% | 1,060株 | -79.22% |
| 2014/10/24 | 日証協 | 107,240株 | +3.17% | 3,600株 | -33.46% | 110,983株 | +1.74% | 5,100株 | -79.07% |
※株式分割は考慮していませんのでご注意ください。
Page Top